| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| December 2008 - 46 products |
|
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 14 Tablet(s) | 9.92 | 27.15 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | | G |  |
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 84 Tablet(s) | 57.92 | 79.10 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 14 Tablet(s) | 10.39 | 27.65 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 84 Tablet(s) | 60.91 | 82.30 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 20mg/5mg | 28 Tablet(s) | 18.41 | 36.35 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 20mg/5mg | 98 Tablet(s) | 52.58 | 73.35 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 40mg/5mg | 28 Tablet(s) | 22.77 | 41.10 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 40mg/5mg | 98 Tablet(s) | 65.53 | 87.35 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 40mg/10mg | 28 Tablet(s) | 23.75 | 42.15 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Vascord 40mg/10mg | 98 Tablet(s) | 71.90 | 94.25 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 10 mg - T | 10 Tablet(s) | 20.11 | 30.30 | 10 % | | Coated tablets: Rivaroxabanum 10 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 10 mg - T | 30 Tablet(s) | 60.34 | 79.55 | 10 % | | Coated tablets: Rivaroxabanum 10 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 10 mg - T | 98 | 207.01 | 233.10 | 10 % | | Coated tablets: Rivaroxabanum 10 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 15 mg | 14 Tablet(s) | 28.90 | 46.65 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 15 mg | 28 Tablet(s) | 56.44 | 75.50 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 15 mg | 98 Tablet(s) | 207.01 | 233.10 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 20 mg | 14 Tablet(s) | 29.08 | 46.85 | 10 % | | Coated tablets: Rivaroxabanum 20 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 20 mg | 28 Tablet(s) | 56.44 | 75.50 | 10 % | | Coated tablets: Rivaroxabanum 20 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| L | SIP | IP | CI | | Xarelto 20 mg | 98 Tablet(s) | 207.01 | 233.10 | 10 % | | Coated tablets: Rivaroxabanum 20 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Valproat chrono Desitin 300 mg ‐ I | 100 Tablet(s) | 8.71 | 25.90 | 10 % | | Delayed release tablets: 2 Active Agents | Desitin Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Valproat chrono Desitin 500 mg ‐ I | 60 Tablet(s) | 9.39 | 26.65 | 10 % | | Delayed release tablets: 2 Active Agents | Desitin Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Anastrozol Sandoz | 30 Tablet(s) | 55.42 | 76.65 | 10 % | | Coated tablets: Anastrozolum 1 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Anastrozol Sandoz | 100 Tablet(s) | 182.48 | 214.80 | 10 % | | Coated tablets: Anastrozolum 1 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Sumatriptan Zentiva 50 mg | 6 | 17.65 | 35.60 | 10 % | | Coated tablets: Sumatriptanum 50 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Sumatriptan Zentiva 50 mg | 12 | 33.62 | 53.00 | 10 % | | Coated tablets: Sumatriptanum 50 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Magnesium Sandoz 243 | 20 | 7.64 | 14.10 | 10 % | | Effervescent tablets: Magnesii Citras 1.23 g | Sandoz
Pharmaceuticals AG | D / SL | FB | | G | |
| | | IP | CI | CM | Magnesium Sandoz 243 | 40 | 13.45 | 24.85 | 10 % | | Effervescent tablets: Magnesii Citras 1.23 g | Sandoz
Pharmaceuticals AG | D / SL | FB | | G | |
| L | SIP | IP | CI | | Actemra 80 mg/4 ml | Durchstechflasche(n) | 129.76 | 157.55 | 10 % | | Concentrate for infusion: Tocilizumabum 80mg / 4ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Actemra 200 mg/10 ml | Durchstechflasche(n) | 324.39 | 369.20 | 10 % | | Concentrate for infusion: Tocilizumabum 200mg / 10ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Actemra 400 mg/20 ml | Durchstechflasche(n) | 648.78 | 722.00 | 10 % | | Concentrate for infusion: Tocilizumabum 400mg / 20ml | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| | | IP | CI | Ph | Deprivita | 30 Tablet(s) | 13.30 | 30.90 | 10 % | | Coated tablets: Hyperici Herbae Extractum Ethanolicum Siccum 900 mg | Permamed AG | B / SL | FB | | G | |
| | | IP | CI | Ph | Deprivita | 90 Tablet(s) | 39.89 | 59.80 | 10 % | | Coated tablets: Hyperici Herbae Extractum Ethanolicum Siccum 900 mg | Permamed AG | B / SL | FB | | G | |
| L | | IP | CI | | Riamet Dispersible | 12 | 12.97 | 30.50 | 10 % | | Tablets: 2 Active Agents | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | SIP | IP | CI | | Xenazine | 112 Tablet(s) | 100.79 | 126.05 | 10 % | | Tablets: Tetrabenazinum 25 mg | Curatis AG | B / SL | FB | | G | |
| | | IP | CI | | Neo-Angin mit Lidocain und
Chlorhexidin Spray | 50 ml | 5.23 | 9.65 | 10 % | | Solution: 2 Active Agents | Doetsch Grether AG | D / SL | FB | | G | |
| | | IP | | | NaCl 0,9% Sintetica,
solution injectable
(ampoules à 5 ml) | 10 1 ampoule(s) à 5 ml | PR | PR | k.A. | | Injection solution: Natrii Chloridum 45mg / 5ml | Sintetica SA | B | FB | | G | |
| | | IP | | | NaCl 0,9% Sintetica,
solution injectable
(vials à 50 ml) | ampoule(s) à 50 ml | PR | PR | k.A. | | Injection solution: Natrii Chloridum 450mg / 50ml | Sintetica SA | B | FB | | G | |
| | | IP | | | NaCl 0,9% Sintetica,
solution injectable
(ampoules à 10 ml) | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Natrii Chloridum 90mg / 10ml | Sintetica SA | B | FB | | G | |
| | | IP | | | NaCl 0,9% Sintetica,
solution injectable
(ampoules à 20 ml) | 5 1 ampoule(s) à 20 ml | PR | PR | k.A. | | Injection solution: Natrii Chloridum 180mg / 20ml | Sintetica SA | B | FB | | G | |
| | | IP | | | NaCl 0,9% Sintetica,
solution injectable
(vials à 100 ml) | ampoule(s) à 100 ml | PR | PR | k.A. | | Injection solution: Natrii Chloridum 900mg / 100ml | Sintetica SA | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 10 mg - T | 30 x 1 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 10 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 10 mg - T | 100 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 10 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 15 mg | 30 x 1 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 15 mg | 100 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 20 mg | 30 x 1 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 20 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Xarelto 20 mg | 100 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 20 mg | Bayer (Schweiz) AG | B | FB | | G | |
